This Big New Development Could Be Bullish for Kenvue Stock
Can tinkering around the edges actually make this stock more attractive? Starboard Value, the activist investing group that's making waves thanks to its new $1 billion stake in Pfizer, now also has a position in the consumer healthcare business Kenvue (KVUE -0.44%). The group will seek to engage with management and propose changes to the company's operations with the aim of unlocking better returns for shareholders than the stock's 10.5% loss since its spinoff from Johnson & Johnson in 2023. The activist's ...